Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Awards & Appointments Department Research University

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

Trial results for first vaccine against blood-stage malaria show it is well-tolerated and offers effective protection

Clinical Trials Publication Research Vaccinology

Results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease – the first inoculation to do so.

Dr. Nicky Whiffin awarded Balfour Lecture 2025

Awards & Appointments Children's Health Department Research

Nicky Whiffin, Associate Professor and Sir Henry Dale Fellow at the University of Oxford’s Big Data Institute and Centre for Human Genetics, has been awarded the 2025 Balfour Lecture by the Genetics Society.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.

Ineos Oxford Institute makes award to OVG project tackling antimicrobial resistance

Awards & Appointments Vaccinology

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded over £2m to six projects across the University of Oxford focused on developing new solutions to tackle antimicrobial resistance (AMR), including one at the Oxford Vaccine Group.

David Cameron resumes role as chair of Advisory Council for Oxford-Harrington Rare Disease Centre (OHC)

Awards & Appointments Public Engagement Research

Former UK Prime Minister David Cameron has resumed his role as chair of the OHC Advisory Council, a position he originally undertook in October 2023 prior to his appointment as Foreign Secretary.

Typhoid vaccine trial confirms sustained protection for older children

Clinical Trials Informing Policy Publication Research Vaccinology

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and icddr,b. But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.

New campaign launched to encourage vaccine uptake

Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation

A major art installation featuring dramatically upscaled bacteria, viruses and a parasite has been unveiled at Oxford University’s Museum of Natural History to celebrate 30 years of vaccine development by the Oxford Vaccine Group (OVG) which has tackled some of the world’s most deadly diseases.

Launch of new podcast series Trusting the Science

Public Engagement Vaccinology

The Oxford Vaccine Group is celebrating 30 years of life-saving vaccine development with the release of a new podcast series of conversations called Trusting the Science. This is the second series of The Oxford Colloquy - discourses hosted by Professor Sir Andrew Pollard who has been Director of the group for over 20 years - and each episode delves into the crucial role that science plays in our understanding of health and immunity.

Athena Swan Gold award

Athena Swan University

The Department of Paediatrics has been awarded the Athena Swan Gold award for its commitment to advancing gender equality in higher education. Established in 2005 to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine (STEMM) employment, the Charter is now used across the globe to address gender equality and barriers to progression that affect women.

New research identifies autoimmunity against a key anti-inflammatory regulator in inflammatory bowel disease

Clinical Trials Department Gastroenterology Immunology Publication Research Research Methods University

A ground-breaking study, published by the New England Journal of Medicine, has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.

Oxford scientists launch first-in-human vaccine trial for deadly Marburg virus

Clinical Trials Recruitment Research Vaccinology

Scientists at the University of Oxford have launched a new clinical trial to test a vaccine to protect people against deadly Marburg virus.

New discovery renews hope for thousands with neurodevelopment disorders

Children's Health Publication Research

A global collaboration led by scientists at the University of Oxford has discovered that genetic variants in a specific gene cause a rare neurodevelopmental disorder (NDD). NDD is a collective term for severe impairments in how the brain functions that impact learning, behaviour, speech, and movement. Most NDDs are thought to be genetic and caused by changes to DNA, however, to date, around 60% of individuals with these conditions do not know the specific DNA change that causes their disorder.

New trial launches for two-in-one vaccine to prevent RSV and hMPV

Children's Health Clinical Trials Research Vaccinology

Scientists at the University of Oxford have launched a phase 1 study to test two investigational mRNA vaccines: one for both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) and a second for RSV alone in infants aged five to eight months old. The vaccines are being developed by Moderna.

Research shows early life immunity increases HIV cure/remission in male infants

Children's Health HIV Publication Research University

New research published by scientists at the University of Oxford, the University of KwaZulu-Natal and the Africa Health Research Institute in South Africa, and the Ragon Institute of Mass General, MIT and Harvard, USA, shows that male infants are more likely to achieve HIV cure/remission than females.

GOSH Charity co-funds two data-driven projects to advance research into childhood cancers

Awards & Appointments Children's Health Research

Great Ormond Street Hospital (GOSH) Charity has joined forces with Cancer Research UK (CRUK) to co-fund two projects that will use data science to advance research into childhood cancers.

New research assesses the function of a major genetic cause of neurodevelopmental disorders

Department Publication Research

New research, published today, has defined the functional impacts of hundreds of variants in a gene that is a major cause of neurodevelopmental disorders.

Professor Teresa Lambe OBE elected to the Fellowship of the Academy of Medical Sciences

Awards & Appointments Department Public Engagement Vaccinology

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

Professor Sir Andrew Pollard elected to the Fellowship of the Royal Society

Awards & Appointments Department Research

Professor Sir Andrew Pollard, Director of the Oxford Vaccine Group at the Department of Paediatrics, and Ashall Professor of Infection and Immunity has today been elected a Fellow of the Royal Society.

Load More